re : will head north

ryderman you hit the nail on the head

big week coming up.

still buying at 44.

investment research - INTERSUISSE

december 2005, only 5 months ago.

here iswhat was said.

" WE ESTIMATE THE VALUE OF CHEMEQ AT $1.73 CENTS PER SHARE. OUR ANALYSIS SUGGESTS THAT THE CHEMEQ PRODUCT IS WORTH $1.96 CENTS PER SHARE. THE BALANCE OF 0.23 CENTS PER SHARE COMES FROM ITS CORRENT DEBT OF 22.5 MILLION. "

As a share holder my eyes lite up with excitement.

the fact that stark hasnt converted its bond into securities suggests it is confident in the boards ability to deliver.

asic allegations : look at solbec pharmaceuticals case.
positive for chemeq. remember both stark and mizuho did due diligence before giving cmq the cash. they must of been happy with there chances.

further capital for expansion : " while the company will manufacture chemeq, it will in most cases distribute its products through distributors. this is necessary in order to achieve comprehensive commercial coverage over the various territories in a timely manner. There is therefore also the possibility that future expansion of capacity could be achieved through the construction of new plants or the licensing of the process in other countries. "

remember CMQ has a superior product. no rivals dont even mention imu. cmq has done huge field trials and is almost over the regulatory hurdles.

cmq holders smile we have the likes of multinationals in the animal antibiotic health market circling.

Alpharma inc . Bayer animal health, Pfizer animal health BASF animal nutrition to name a few.

time to get excited.

I LOVE CMQ HATERS :)